Daily Stock List
Writers' Group Film Corp. (WRIT)
All In Stocks, StockHideout, Penny Stocks Finder, Stock Twiter, Stock Roach, Penny Dreamers, Bullseyestox.com, Actual Gains, PennyStockRumors.net, and SmallCapVoice reported earlier on Writers' Group Film Corp. (WRIT), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Incorporated in Delaware on March 9, 2007, Writers' Group Film Corp. is a content creation company. The Company focuses on the production, acquisition, and distribution of live concerts in three dimensional formats (3D) for digital broadcast into digitally-enabled movie theaters in the U.S. and worldwide. Front Row Networks, Inc. (incorporated on July 27, 2010 in the State of Nevada) is a wholly owned subsidiary of the Company.
Writers' Group Film has their headquarters in Beverly Hills, California. The Company's management has proven industry leadership and has worked with widely recognized industry talent and critically acclaimed creative talent. Writers' Group Film lists on the OTC Markets: OTCQB.
The intention of the Company's concept is to present live concerts in 3D, at lower ticket prices, to a massive fan base around the world in a cost-effective manner. Their intention is to license their products in 2D and 3D format to DVD and Blu-Ray retailers, TV broadcasters, cable and 3D cable channels, and mobile streaming providers. Moreover, the Company's Management intends to sell merchandising and sponsorship, specific to each artist in the concert, in theaters. They will sell merchandise, such as clothing, household goods, and other products in movie theaters, where the live concert is exhibited.
The Front Row Networks subsidiary will take advantage of their distribution networks and their licensing and merchandising relationships by acquiring 2D and 3D concert footage that has already been produced. They will convert their 2D catalogue into a digital 3D format. This will allow them to package and sell all of their acquired content to digital broadcasters around the globe.
In July 2012, Writers' Group Film announced that their wholly owned subsidiary, Front Row Networks, reached an agreement with SENSIO Technologies, Inc. (TSX-V: SIO) to bring Live 3D events to cinemas.
SENSIO (a Montreal-based 3D technology company) is a pioneer in 3D-image processing with their award-winning technology, SENSIO® Hi-Fi 3D.
Writers' Group Film Corp. (WRIT), closed Thursday's trading session at $0.0009, up 12.50%, on 1,135,600 volume with 8 trades. The average volume for the last 60 days is 5,921,613 and the stock's 52-week low/high is $0.0006/$0.0095.
Dot Hill Systems Corp. (HILL)
Wall Street Resources reported earlier on Dot Hill Systems Corp. (HILL), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Listed on the NASDAQ Global Market, Dot Hill Systems Corp. is a leading provider of SAN storage solutions. They help IT to improve performance, increase availability, simplify operations, as well as reduce costs. They do so by leveraging their proprietary Assured family of storage solutions. Dot Hill has their headquarters in Longmont, Colorado. The Company has offices and/or representatives in China, Germany, Japan, United Kingdom, Singapore and the United States. Dot Hill Systems sells their products mainly via original equipment manufacturers (OEMs), systems integrators, distributors, and value added resellers.
The Company's RAID technology is the foundation for best-in-class storage solutions offering enterprise-class security, availability and data protection. Dot Hill's product families include the AssuredSAN™ storage systems and associated data protection software, and AssuredVRA™ host-based RAID software. The Company offers entry-level and mid-range storage under the AssuredSAN name. These arrays feature several series, ranging from the newest AssuredSAN 3003 arrays to the entry-level AssuredSAN 2002 Series.
The Company's solutions combine innovative software with the industry's most flexible and extensive hardware platform and automated management to deliver best in class solutions. Dot Hill Systems has deployed over 500,000 storage systems worldwide. Dot Hill innovation has resulted in several patent awards on their technologies. Their solutions are well suited for emerging trends including virtualization, cloud computing and accelerating demand for data storage related to email, databases, and high-performance computing.
Dot Hill's end-user customers include IT managers in media and entertainment, retail, finance, education, defense, healthcare and government. These customers utilize the Company's unified storage solutions for video streaming, high definition video production, transaction processing, and intelligence gathering and an array of business applications.
Today, Dot Hill Systems announced that Hanif Jamal, their Chief Financial Officer, is scheduled to present at the 5th Annual LD Micro Conference, taking place December 6, 2012 at the Luxe Hotel in Los Angeles, California. Dot Hill's group presentation is scheduled for 8:30 a.m. (PT). Company Management will be available for one-on-one meetings throughout the day.
Dot Hill Systems Corp. (HILL), closed Thursday's trading session at $0.92, up 1.10%, on 62,459 volume with 133 trades. The average volume for the last 60 days is 93,203 and the stock's 52-week low/high is $0.72/$1.65.
AlumiFuel Power Corp. (AFPW)
OTCPicks, Penny Stock Rumble, and Purely Penny Stocks reported earlier on AlumiFuel Power Corp. (AFPW), and we highlight the Company, here at the QualityStocks Daily Newsletter.
AlumiFuel Power Corp., operating via their subsidiaries, is an early production stage alternative energy enterprise. They generate hydrogen gas and steam/heat by way of the chemical reaction of aluminum, water, and proprietary additives. This technology is ideally suited for several applications requiring on-site, on-demand fuel sources, serving National Security and commercial customers. AlumiFuel Power's shares trade on the OTC Markets: OTCQB.
AlumiFuel's hydrogen feeds fuel cells for portable and back-up power; fills inflatable devices such as weather balloons; and provides fuel for flameless heater applications. They can replace expensive, hard-to-handle, and high pressure K-Cylinders. Their hydrogen/heat output is also undergoing design and development to drive fuel cell-based and turbine-based undersea propulsion systems and auxiliary power systems.
The Company offers PBIS-1000 portable balloon inflation devices, which enables on the spot generation of hydrogen. AlumiFuel has major differentiators in performance, adaptability, safety, and cost-effectiveness in their target market applications, with no external power required and no toxic chemicals or by-products.
AlumiFuel Power has their PBIS-200 system. The system can be easily transported and quickly deployed for launching 30g pilot balloons in remote locations worldwide. The PBIS-200 is a scaled down version of the PBIS-2000, designed and engineered to provide lift gas for 200g weather balloons. The PBIS-200 generates 200 litres of hydrogen in less than 15 minutes using only one 32oz. AlumiFuel cartridge.
As with the PBIS-2000, the PBIS-200 operates at ambient pressure and low temperatures, and is housed in a ruggedized Hardigg case. With the reduced size of the unit, the new system would weigh only approximately 50 pounds.
Yesterday, AlumiFuel Power announced that their wholly owned operating subsidiary, AlumiFuel Power Technologies, Inc., signed a Technology Development Agreement with Genport North America (GNA), the U.S. subsidiary of the Italian hybrid power sources company, Genport srl.
The provisions of the agreement include the establishment of a U.S.-based Joint Venture (JV). The JV would combine and integrate the technologies, Intellectual Property (IP), products, revenues, engineering staffs, manufacturing operations, and marketing, sales and services activities of the two companies. The focus of the JV is to synergistically pursue and capture backup and portable power applications and business opportunities in the United States, Europe, and other market regions.
AlumiFuel Power Corp. (AFPW), closed Thursday's trading session at $0.0001, even for the day, on 34,250,000 volume with 19 trades. The average volume for the last 60 days is 67,658,318 and the stock's 52-week low/high is $0.0001/$0.0032.
Newtek Business Services, Inc. (NEWT)
RedChip, Investor Ideas, and Wall Street Resources reported earlier on Newtek Business Services, Inc. (NEWT), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.
Based in New York City, Newtek Business Services, Inc., The Small Business Authority, distributes a spectrum of business services and financial products to the small- and medium-sized business market under the Newtek® brand. The Small Business Authority is a brand of the Company. The establishment of the Small Business Authority brand has been to provide real-time, state of the art content and business services to become the destination for small-business owners all across the United States.
Newtek provides their services to more than 100,000 business accounts. Newtek Business Services processes electronic payments in excess of $4 billion each year. The Company has positioned the Newtek™ brand as a one-stop-shop provider of business services. The Company provides an array of products and services including Electronic Payment Processing, Managed Technology Solutions (Cloud Computing), eCommerce, Business Lending, Insurance Services, Web Services, Data Backup, Storage and Retrieval, Accounts Receivable Financing, and Payroll.
The mission of Small Business Authority is to provide the small-business community with the experts, services, technologies, as well as resources needed to succeed in today's competitive and ever-changing marketplace. Their primary purpose is to help businesses grow revenues, reduce expenses, and minimize risks.
The Small Business Authority's Business Lending Division is a nonbank lender. They provide end-to-end financing solutions, specializing in helping businesses acquire needed funds. Their Merchant Processing Service provides a high-quality, customized program and pricing structure so businesses can accept noncash payments. The Small Business Authority's Web Services include web design, web hosting, and internet marketing.
This month, Newtek Business Services announced that they are formally launching their "Newtek Advantage" cloud-based operating platform. The Newtek Advantage is a mobile real-time SMB management platform. It puts all critical transactions of a small-to-medium-sized business, and economic, ecommerce and web site traffic data on the business's smartphone, tablet, laptop or PC. The Newtek Advantage provides the actionable intelligence that businesses and technicians will require and use in the future of mobile eCommerce. Newtek will be launching future applications generated from The Newtek Advantage platform within the next two quarters featuring "Payroll in the Cloud" and "Insurance in the Cloud".
Newtek Business Services, Inc. (NEWT), closed Thursday's trading session at $1.88, up 1.62%, on 3,261 volume with 10 trades. The average volume for the last 60 days is 29,833 and the stock's 52-week low/high is $1.00/$2.11.
WidePoint Corp. (WYY)
Hayden IR and Buzz Stocks reported on WidePoint Corp. (WYY), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Headquartered in Oakbrook Terrace, Illinois, WidePoint Corp. is a leading provider of wireless mobility management and cyber security solutions. The Company provides their solutions using their advanced information technology products and services. WidePoint has grown via the merger of highly specialized regional Information Technology (IT) consulting companies, most of who have been in business for decades.
WidePoint enables organizations to deploy fully compliant IT services in accordance with government-mandated regulations and advanced system requirements. The Company has several wholly owned subsidiaries holding major government and commercial contracts. These include Operational Research Consultants, Inc., iSYS, LLC, Protexx, Advanced Response Concepts Corp., WidePoint Solutions/AGS and WidePoint IL.
As pertains to Forensic Informatics, they provide Forensic Laboratory information technology needs to federal, state, and local law enforcement agencies throughout the U.S. Pertaining to Identity Management, their information assurance services and systems are vital to maintaining the nation's security and leadership in technology. Their services range from Certification and Accreditation to System Architecture and Customizable Information Assurance plans and processes.
Concerning Wireless Telecommunications Expense Management, WidePoint applies on-staff expertise and proven solutions to manage wireless expenses for complex communication networks of cellular phones, Blackberries, PDAs, air cards, pagers and other devices.
In addition, WidePoint provides consulting services in the areas of Strategic Planning, Independent Verification and Validation, Help Desk Support, Training and Curriculum Development, Business Process Re-engineering, Security Architectural Analysis, Disaster Planning and Recovery, and Graphics Support. They offer architecture and planning services, software implementation services, and IT outsourcing.
This month, WidePoint announced financial results for the three months ended September 30, 2012. Net revenue increased 42 percent to $15.2 million from $10.7 million in the prior year's comparable period. Telecommunications Management segment revenue increased 15 percent to $7.1 million from $6.2 million in last year's comparable period. CyberSecurity Managed Solutions segment revenue increased 48 percent to $2.3 million from $1.6 million in the prior year's comparable period. IT Consulting Services and Products revenues increased to $5.8 million from $2.9 million in last year's comparable period.
Gross profit was approximately $3.6 million, or 23 percent of revenues, compared to gross profit of $2.6 million, or 24 percent of revenues, for the third quarter of 2011. Income from operations was approximately $459,000 compared to approximately $270,000 in last year's comparable period. Net income was approximately $244,000, compared to $218,000 in the prior year's comparable period. Non-GAAP adjusted EBITDA was approximately $1,035,000 as compared to $544,000 in last year's comparable third quarter.
WidePoint Corp. (WYY), closed Thursday's trading session at $0.40, even for the day, on 8,056 volume with 17 trades. The average volume for the last 60 days is 50,065 and the stock's 52-week low/high is $0.35/$0.97.
Tidelands Bancshares, Inc. (TDBK)
We are highlighting Tidelands Bancshares, Inc. (TDBK), here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets (OTCQB), Tidelands Bancshares, Inc. operates as the bank holding company for Tidelands Bank. As of March 31, 2012, Tidelands operated seven full service banking offices in Charleston, Dorchester, Berkeley, Horry, Georgetown, Beaufort, and Jasper counties in South Carolina. Founded in 2002, Tidelands Bancshares has their corporate headquarters in Mount Pleasant, South Carolina.
Tidelands Bank is a local bank that provides banking products and services to professionals, entrepreneurs, small business owners, as well as families of the South Carolina coastal area. The doors of their first branch, a 10,000 square foot building, opened in October of 2003. Tidelands Bank has local decision making authority; this ensures they can provide answers based on an understanding of the community and the customer.
Tidelands' deposit products consist of checking, commercial, savings, transaction, and individual retirement accounts. They also consist of other time deposits ranging from daily money market accounts to longer-term certificates of deposit.
Their loan portfolio includes commercial and residential real estate mortgage, real estate construction, commercial and industrial, and consumer loans. In addition, Tidelands Bancshares offers safe deposit boxes, travelers' checks, direct deposit, U.S. savings bonds, banking by mail, courier deposit, Internet banking, bill payment, and cash management services. Furthermore, they offer remote deposit capture, Automated Clearing House (ACH) origination, and mobile banking services.
Business banking solutions include checking and savings account options tailored for specific businesses. Tidelands Bancshares provides Remote Capture for deposits and ACH Origination for payments and payroll. Additionally, they offer loan options to meet the needs of a growing business enterprise.
Pertaining to Commercial Loans, Tidelands Bancshares offers term loans and lines of credit; owner occupied building loans; investment property (apartments, office buildings, and more), as well as equipment loans. Concerning Consumer Loans, the Bank will create custom loan packages tailored to meet a customer's specific individual needs. These include home equity lines of credit, auto loans, and boat loans.
Tidelands Bancshares, Inc. (TDBK), closed Thursday's trading session at $0.35, up 16.67%, on 21,822 volume with 1 trade. The average volume for the last 60 days is 5,503 and the stock's 52-week low/high is $0.055/$0.66.
Golden Dawn Minerals, Inc. (GOM.V)
We are highlighting Golden Dawn Minerals, Inc. (GOM.V) today, here at the QualityStocks Daily Newsletter.
Trading on the TSX Venture Exchange, Golden Dawn Minerals, Inc. is a production oriented, junior resource exploration company. The Company's flagship property is the Greenwood Precious Metals Project. Golden Dawn has Gold & Silver production slated to begin within 12‐18 months at two historic mines: the May Mac Mine and the Wild Rose Mine. Golden Dawn Minerals has their headquarters in Vancouver, British Columbia.
The May Mac Mine is a high-grade, silver-gold deposit (surface & underground sampling, ground geophysics & drilling). The Wild Rose Mine is a high-grade, gold-copper sulphide quartz carbonate vein. The Wild Rose Mine will begin production shortly after the May Mac Mine. The expectation is that a 10,000-ton bulk sample will be mined from the Wild Rose Mine in 2013.
In addition, the Company's Deadwood Zone is a potential open-ended bulk tonnage gold system (2,000 meters long, 300 meters wide and 300 meters deep). The Deadwood Zone is within the Tam O'Shanter and Wild Rose claims. The Company has a 10,000-meter diamond drill program planned for 2013. The target objective is to expand the Deadwood Zone's gold resource to 1M ounces. A Preliminary Economic Study is on the horizon to determine the commercial viability of the deposit.
Today, Golden Dawn Minerals' Wolf Wiese, CEO of the Company, reported a significant increase in the size of the Deadwood Gold Zone. On July 13, 2011, the Company announced a National Instrument 43-101 maiden Inferred Mineral Resource for the Deadwood Gold Zone, located on their Greenwood Precious Metal Project 2 km from Greenwood, South Central British Columbia. Golden Dawn initially announced an Inferred Mineral Resource of 19.4 million tonnes at an average grade of 0.45 grams per tonne (g/t) gold (Au), yielding 279,300 troy ounces of Au utilizing a 0.3 g/t lower cut-off grade.
The Company completed 8 drill holes during a phase 2 drilling program in the late fall of 2011 designed to test further the Deadwood Gold Zone at depth and along strike to the northwest and southeast of the existing Inferred Mineral Resource. All 8 drill holes completed during the phase 2 drilling intersected similar mineralization in grade and thickness to the Inferred Mineral Resource for the Deadwood Gold Zone.
Golden Dawn Minerals has engaged APEX Geoscience Ltd. to update the existing resource model with the new drilling results. The Company is planning a drill program starting at the end of January 2013, to extend further the resource of gold, silver and copper mineralization of the Deadwood Gold Zone.
Golden Dawn Minerals, Inc. (GOM.V), closed Thursday's trading session at $0.05, up 42.86%, on 760,665 volume. The stock's 52-week low/high is $0.03/$0.21.
All American Pet Company, Inc. (AAPT)
Stock Analyzer, OTCPicks, PennyTrader Publisher, Penny Stock Rumble, AllPennyStocks, StockHideout, and SmallCapVoice reported earlier on All American Pet Company, Inc. (AAPT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
All American Pet Company produces, markets, and sells natural super-premium and premium patented wellness products under proprietary brand names specifically for dogs. The Company's corporate mission is keeping 80 million dogs eating all natural, made in the United States, super premium products, with meat first ingredients, in a high protein formula, providing an abundance of amino acids and chelated minerals that can fit into one's purse or pocket. All American Pet Company lists on the OTCQB; the Company has their headquarters in Los Angeles, California.
All American Pet's products include Chompions® - a heart-healthy multi-meal dry kibble with amino acids, and MUTTS™ - a food for dogs that has 25 percent natural meat protein. They also offer MUTT BARS™ - a bar for dogs with super premium protein, vitamins, minerals and energizing fats.
The Company also offers CHOMPBARS™. These bars are available in three varieties: original 25 percent protein, an 8 percent low fat formula, and a senior formula providing joint support. In addition, they offer CHEWIES™. These are a protein rich (25 percent), nutrient dense, all natural, super premium treat that comes in three flavors: bacon, cheese and peanut. CHEWIES™ are a snack fortified with heart healthy amino acids and minerals.
Furthermore, All American Pet offers their NutraBar™ - a food bar for dogs with 27 percent protein and performance enhancements. They also offer PAWtizer™ - an alcohol free antibacterial "wash" for dogs.
Today, All American Pet announced that they are ready to fill, on December 1, 2012, the shelves of the 60,000 retailers that have approved their NutraBar™ and PAWtizer™ products. The bars will also be available on the brand's e-commerce site. NutraBar™ is a nutrient rich, protein bar that can serve as a meal, a meal supplement, or healthy snack. In addition, the product is portable and convenient for consumers.
All American Pet Company, Inc. (AAPT), closed Thursday's trading session at $0.022, up 0.46%, on 1,871,568 volume with 51 trades. The average volume for the last 60 days is 1,497,571 and the stock's 52-week low/high is $0.0007/$0.0795.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.19, up 5.56%, on 234,838 volume with 46 trades. The stock’s average daily volume over the past 60 days is 116,129, and its 52-week low/high is $0.171/$0.68.
International Stem Cell Corp. reported today on successfully achieving a critical milestone today on the company's road to fully developing their stem cell therapy technology, with the R&D team turning out the world's first human, clinical-grade stem cell lines capable of immune-matching millions. This is a significant step up from the existing research-grade human parthenogenetic stem cell (hpSC) lines and places the company in the pole position for conducting U.S. clinical trials, a tremendous victory that is three years in the making for ISCO and stretches back to initial development in Moscow by the company's scientific founder, Dr. Elena Revazova.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Significant Progress Towards Clinical Development
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Latest Product Launch
International Stem Cell Corp Announces Third Quarter 2012 Financial Results
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.21, up 9.09%, on 205,397 volume with 113 trades. The stock’s average daily volume over the past 60 days is 215,422, and its 52-week low/high is $0.17/$0.42.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
"Cardium Announces Patent Award For Rights To Gene Therapy for Coronary Heart Disease, Resolves Long-standing IP Competition"
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $8.08, off by 1.46%, on 11,690 volume with 32 trades. The stock’s average daily volume over the past 60 days is 50,287, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
DoMark Internatioxnal, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.24, on 349,476 volume with 87 trades. The stock’s average daily volume over the past 60 days is 104,943, and its 52-week low/high is $0.27/$4.88.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
DoMark International Subsidiary and Leader in Infrared/Solar Apple Accessories, SolaWerks™, Launches New Website
SolaWerksTM Extending Lead in Mobile Energy by Adding Infrared to Its Solar Powered Apple Accessory Products
DoMark Subsidiary SolaWerks Next Generation Technology Slated for Release
International Stem Cell Corp., a biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), has achieved a critical milestone towards the clinical development of its non-embryonic stem cell therapy.
Through much dedication and hard work, the company’s research and development team has created the world’s first human clinical-grade stem cell lines that can be immune-match to millions of individuals. ISCO’s existing research-grade parthenogenetic stem cell lines, one of which may be an immune-match to approximately 70 million people, are being used in pre-clinical development. ISCO is now in a position to conduct clinical trials in the United States.
“We’ve been working diligently for three years to perfect this technology, which was first developed by our scientific founder, Dr. Elena Revazova in Moscow, and I’m excited to report that we have been able to derive new stem cell lines in the United States under the US and California regulatory frameworks. I’m optimistic that the new parthenogenetic stem cell lines, by providing a potentially unlimited supply of cells and tissue for transplantation, will be of great benefit to the medical community and patients world-wide,” stated Dr. Semechkin, CEO and Co-Chairman of the Board.
Created using ISCO’s proprietary technology, the new stem cell lines represent the first of a new generation of clinical-grade human parthenogenetic stem cell (hpSC) lines created in the United States under US regulatory oversight and designed to meet FDA regulations. The US Food and Drug Administration developed Good Tissue Practice (GTP) and Good Manufacturing Practice (GMP) standards to ensure the safety of products developed for clinical use. Conforming to GMP is necessary to conduct clinical development programs.
Independent third-party testing has confirmed the new lines to be “homozygous” in the HLA coding regions. This means that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection; a distinct clinical advantage over embryonic stem cells. The company anticipates the new lines to immune-match millions of individuals. They will be added to ISCO’s existing bank and provide a platform from which to develop cells and tissue for clinical use.
“The importance of this breakthrough cannot be overstated,” emphasized Dr. Craw, Executive Vice President of ISCO. “Expanding our collection is not only important for our therapeutic programs, but also further establishes our leadership position in human stem cell technology. Achieving this critical milestone moves us along the path to make the transition into a clinical stage company.”
To learn more about ISCO and its superior stem cell technology, visit www.InternationalStemCell.com
Coal and other fossil fuels have been the energy foundation of the industrialized world, providing the power to essentially move the earth, allowing us to reorganize virtually everything to suit our own perceived purposes. But all of this energy comes from someplace, and that someplace is the sun, or, more specifically, the sun from millions of years ago. In the case of coal, it comes from plants that captured solar energy, were ultimately buried, and are now being dug up in the form of coal to release that stored up energy. (It’s much the same with oil, except that oil comes primarily from the remains of ancient animals that ate some of those plants.) These fossil fuels are efficient and convenient stores of energy, ready to burn whenever and wherever needed, including in power plants where coal is used to generate nearly half of all the electricity produced.
But more than energy is released when coal or other fossil fuels are burned, and therein lies the problem. When those plants were living things, they also captured carbon from the air, using the sun’s energy to combine carbon with hydrogen to form the compounds that eventually became coal. When coal is burned, that ancient carbon is released back into the atmosphere in the form of carbon dioxide (CO2), the greenhouse gas that is causing so much consternation today. Going through the massive process of shutting down all of those coal-fired power plants, and bringing online wind or solar or other renewable sources is daunting and expensive. Power plants based on combustion are a tried and true technology all over the world, not requiring sunny or windy days to operate efficiently, but coal is also the single biggest air polluter.
Viaspace, a renewable energy company, has found a way for the world to continue enjoying the proven convenience and dependability of combustion-based electricity with none of the downside. Viaspace is the proprietary holder of Giant King Grass, one of the highest yielding biomass crops in the world. Rather than using unpredictable and difficult to transport waste materials for renewable power sources, the idea is to use Giant King Grass as a dedicated and controllable energy source. In various parts of the world, it can be grown right alongside the power plants it is designed to feed, or it can be pelletized for easy transport anywhere it is needed. But, most importantly, Giant King Grass is carbon neutral, meaning that the CO2 emitted when burned is offset by the absorption of CO2 during its growth. In effect, Viaspace is able to grow its own coal.
For more information, visit www.viaspace.com
Envivio, a prominent supplier of live and on-demand multi-screen IP video processing and delivery solutions, announced that Envivio encoding solutions have been deployed by LG U+ to power its new LG u+tv G multi-screen service. This service is the first offering in South Korea boasting support for Google TV. LG u+tv G uses an Internet-connected set-top box to give subscribers access to live channels and on-demand TV integrated with apps, including Search, YouTube, Google Play, and Chrome.
LG U+ is currently using Envivio encoders to run its TV Everywhere service, providing over 126 channels of video to TVs, PCs, tablets, and smartphones. LG U+ is a subsidiary of LG Group and a major telecommunications service provider in Korea.
“We are excited to be able to offer the LG u+tv G service to our subscribers as another way to experience television in an interactive fashion,” said Hyunil Moon, general manager of the IPTV business team at LG U+. “The Envivio encoders were selected because they provided the best video quality at any given bitrate, on any device. This decision was reinforced by the fact that our previous implementation of multi-screen with the Envivio systems has proven to be an extremely reliable, robust architecture.”
“LG U+ is an innovative operator, and the introduction of this new Google TV service takes their video service to the next level,” said Julien Signès, Envivio’s president and CEO. “At Envivio, we are committed to providing solutions that offer the flexibility and scalability our customers need, with the feature set to support traditional TV and advanced applications on any viewing device.”
Envivio Muse™ Live and On-Demand software encoders/transcoders provide high quality video to any device on any network in all formats. Envivio Muse can be upgraded with minimal effort due to its converged architecture and feature-rich, software based design. The system runs on the Envivio 4Caster™ Intel-based appliances or HP blade servers.
For further information, visit www.envivio.com
Santa Fe Gold, the ambitious and relatively young mineral developer focused primarily on their flagship Summit silver-gold project (including the underground mine and surrounding 117 patented acres, and 740 unpatented acres) and the associated Banner milling facility in Lordsburg, was overjoyed to report bonanza-grade gold and silver values occurring over mineable widths at Summit today.
We are talking grades of 7.73 opt Au and 269.75 opt Ag, the best results thus far to be pulled at the project. It’s a clear indication that the northern edge of the currently defined resource (especially in light of ongoing explorative work) where the assay material was pulled shows abundant potential for expansion. SFEG is looking at being able to expand northwest along-strike now through high-grade gold and silver, having kicked up this superb news while pursuing the 5600 level of the N-1 ore block.
VP of Operations for SFEG, John White, noted how these findings roundly confirm the company’s model for the N-1 mineralization and have created a great deal of exuberance at SFEG, instilling confidence in the procedural northwesterly movement to the point where the men are actually hungry to get at the metal. The epithermal vein system pattern for Summit is well known to all and here we have solid indicators that digging out more of the NW area will lead to additional high-grade mineralization outside currently identified resources. This could be huge for SFEG and the realization that such additional production potential is within reach has had an electrifying effect on people.
Hitting this kind of potential while working your way through the material is a real boon for SFEG, and though the current assay bonanza returns are likely more highly localized, it is precisely this sort of localized mineralization that is a classic hallmark of epithermal vein systems in this geology. The assays results were encountered near a surface drill hole intersection that returned an 11.4 foot true width at 0.214 opt Au and 16.42 opt Ag, with face channel samples from a three consecutive round interval showing an average of 2.14 opt Au and 82.68 opt Ag over 12.7 feet. An additional 6-foot interval from the same zone yielded the brilliant 7.73 opt Au and 269.75 opt Ag figures.
SFEG will also continue drift development below the 5300 level as they edge towards the high grade stuff down on the 5080 level, a progress target which the company anticipates hitting by the middle of next year. There is plenty of mining to be done within the broad, structurally controlled zone of epithermal mineralization bearing volcanic rock (hydrothermally altered) at Summit and the company has five years of ore reserve just in the main footwall zone (some 618k tons at 0.143 opt Au and 10.78 opt Ag).
Production, discoveries that align with a clear geology model for the mineralization, and growing reserves; it’s a recipe for success and SFEG has their sights set on the big time, with everyone across the company’s asset portfolio driving hard to make Santa Fe the next major player in precious metals development.
For more information on Santa Fe Gold, visit www.SantaFeGoldCorp.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Cardium Therapeutics, Inc. (CXM) Announces the Acquisition of To Go Brands
- Consorteum Holdings, Inc. (CSRH) Subsidiary, Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming with the Acquisition of To Go Brands
- GlobalWise Investments, Inc. (GWIV) Teams Up With MWA Intelligence to Participate in Two Imaging Channel Conferences
- GreeneStone Healthcare Corp. (GRST) Seeks Amex Listing - New Report Confirms Demand
- International Stem Cell Corp. (ISCO) Lifeline Cell Technology Products to Be Added to Fisher Scientific's Catalogs
- Loans4Less.com, Inc. (LFLS) Provides Preliminary Financial Results for the Third Quarter of 2012
- Skinny Nutritional Corp. (SKNY) to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
- TNI BioTech Inc. (TNIB) and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
- VistaGen Therapeutics, Inc. (VSTA) Completes $3.25 Million Financing and $3.0 Million Debt Restructuring